Identification of Hypericin as a Candidate Repurposed Therapeutic Agent for COVID-19 and Its Potential Anti-SARS-CoV-2 Activity

The COVID-19 pandemic has had an unprecedented impact on the global economy and public health. Its etiologic agent, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is highly transmissible, pathogenic and has a rapid global spread. Currently, the increase in the number of new confirm...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Aline da Rocha Matos, Braulia Costa Caetano, João Luiz de Almeida Filho, Jéssica Santa Cruz de Carvalho Martins, Michele Gabrielle Pacheco de Oliveira, Thiago das Chagas Sousa, Marco Aurélio Pereira Horta, Marilda Mendonça Siqueira, Jorge Hernandez Fernandez
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Frontiers Media S.A. 2022-02-01
Saila:	Frontiers in Microbiology
Gaiak:	SARS-CoV-2 COVID-19 Hypericin RdRp Mpro drug repurposing
Sarrera elektronikoa:	https://www.frontiersin.org/articles/10.3389/fmicb.2022.828984/full
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!